Surgery for gastric cancer: 10-Year experience worldwide

Gastric Cancer

Volumn 4, Issue 4, 2001, Pages 166-174

  Adachi, Yosuke ^a   Kitano, Seigo ^a   Sugimachi, Keizo ^b  

^a OITA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Cancer; Gastric cancer; Lymph node dissection; Lymph node metastasis; Quality of life; Surgery

Indexed keywords

CANCER SURGERY; CANCER SURVIVAL; EARLY DIAGNOSIS; ENDOSCOPIC SURGERY; EUROPE; HUMAN; INTERNATIONAL COOPERATION; JAPAN; LAPAROSCOPIC SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; MORBIDITY; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; STOMACH CANCER; STOMACH MUCOSA; SURGICAL TECHNIQUE;

GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; PROGNOSIS; SPLENECTOMY; STOMACH NEOPLASMS; TIME FACTORS;

EID: 0035722262     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-001-8007-7     Document Type: Review

References (107)

1. Improving survival in gastric cancer: Review of operative mortality in English language publications from 1970
2. Improving results in the treatment of gastric cancer: An 11-year audit
3. Gastric cancer: A curable disease in Britain
4. Survival in stomach cancer is improving: Results of a nationwide population-based Swedish study
5. Changing pattern of histologic type, location, stage and outcome of surgical treatment of gastric carcinoma
6. Population-based study of diagnosis, treatment and prognosis of gastric cancer
7. The Turkish experience with curative gastrectomies for gastric carcinoma: Is D2 dissection worthwhile?
8. Cancer of the stomach: A patient care study by the American College of Surgeons
9. Adenocarcinoma of the stomach: Are we making progress?
10. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients
11. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial
12. Extended lymph-node dissection for gastric cancer
13. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial
14. A clinicopathological study of asymptomatic gastric cancer
15. Delays in the diagnosis of esophagogastric cancer: A consecutive case series
16. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists
17. Racial factors cannot explain superior Japanese outcomes in stomach cancer
18. Is gastric carcinoma different between Japanese and the United States?: A comparison of patient survival among three institutions
19. Prognostic significance and surgical management of lymph node metastasis in gastric cancer
20. Lymph node metastases of gastric cancer: General pattern in 1931 patients
21. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma
22. Prognostic significance of the number of metastatic lymph nodes in patients with gastric cancer
23. Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathological and treatment factors
24. Lymphadenectomy in gastric carcinoma: A prospective and prognostic study
25. Prognostic significance of lymph node dissection in gastric cancer
26. Prognostic significance of lymph node metastasis in advanced carcinoma of the stomach
27. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma
28. Prognostic significance of the number of positive lymph nodes in gastric carcinoma
29. Classification of regional lymph node metastasis from gastric carcinoma
30. The number of metastatic lymph nodes: A promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification
31. Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system
32. Evaluation of the new American Joint Committee on Cancer/International Union Against Cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification
33. Superiority of a new UICC-TNM staging system for gastric carcinoma
34. A comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage in gastric carcinoma
35. Lymph node staging in gastric cancer: Is location more important than number?
36. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer
37. Perigastric lymph nodes with metastasis in gastric cancer
38. Immunohistochemical detection of lymph node microinvolvement in node-negative gastric cancer
39. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction
40. Micrometastasis in lymph nodes of mucosal gastric cancer
41. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer
42. Prognostic significance of immunohistochemical micrometastases in node-negative gastric cancer patients
43. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence
44. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcriptase-polymerase chain reaction in patients with gastrointestinal or breast carcinomas
45. Biological behaviour and clinical implications of micrometastases
46. The role of lymph node surgery in gastric cancer
47. Progress in gastric cancer surgery in Japan and its limits of radicality
48. Is D2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator?
49. Prognostic relevance of systemic lymph node dissection in gastric carcinoma
50. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastasis
51. Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer based on a new concept: A prospective long-term follow-up study
52. Extensive versus limited lymph node dissection for gastric cancer: A comparative study of 320 patients
53. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma
54. Gastric carcinoma: Does lymph node dissection alter survival?
55. Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma
56. Role of lymph node dissection and splenectomy in node-positive gastric carcinoma
57. The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
58. Will Rogers and gastric carcinoma
59. Ignoring small lymph nodes can be a major cause of staging error in gastric cancer
60. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japanese and Western countries
61. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer
62. Total versus subtotal gastrectomy: Surgical morbidity and mortality rates in a multicenter Italian randomized trial
63. Subtotal versus total gastrectomy for gastric cancer: 5-Year survival rates in a multicenter randomized Italian trial
64. D1 versus D2 dissection for gastric cancer
65. D1 versus D2 dissection for gastric cancer
66. Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer
67. Surgery for gastric cancer
68. Radical surgery for gastric cancer: A review of the Japanese experience
69. Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma
70. Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma
71. Prognostic impact of splenectomy on gastric cancer: Results of the Korean Gastric Cancer Study Group
72. Preservation of the spleen improves survival after radical surgery for gastric cancer
73. Role of splenectomy in gastric cancer surgery: Adverse effect of elective splenectomy on longterm survival
74. Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma: Univariate and multivariate analyses
75. End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric carcinoma
76. Splenectomy in cancer gastrectomy: Recommendation of spleen-preserving for early-stages
77. Splenectomy for treatment of gastric cancer: Japanese experience
78. Japanese classification of gastric carcinoma: 2nd English ed.
79. Prognostic factors in gastric carcinoma: Results of the German Gastric Carcinoma Study 1992
80. Relevant prognostic factors in gastric cancer: 10-Year results of the German Gastric Cancer Study
81. The most important prognostic factors for gastric cancer patients: A study using univariate and multivariate analyses
82. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer
83. Pathology and prognosis of gastric cancer: Findings in 10 000 patients who underwent primary gastrectomy
84. Dukes's classification: A valid prognostic indicator for gastric cancer
85. Proximal compared with distal adenocarcinoma of the stomach: Differences and consequences
86. Surgical treatment of adenocarcinoma of the cardia
87. Proximal gastric cancers resected via a transabdominal-only approach: Results and comparisons to distal adenocarcinoma of the stomach
88. Characteristics and clinical outcome of proximal-third gastric cancer
89. Adenocarcinoma of the esophagogastric junction: Classification in 1002 consecutive patients
90. Endoscopic mucosal resection for treatment of early gastric cancer
91. Laparoscopic wedge resection of the stomach for early gastric cancer using a lesion-lifting method
92. Laparoscopic wedge resection of gastric submucosal tumors
93. Laparoscopy-assisted Billroth I gastrectomy
94. Laparoscope-assisted Billroth I gastrectomy
95. Laparoscopic Billroth II gastrectomy for early gastric cancer
96. Hand-assisted laparoscopic distal gastrectomy with abdominal wall-lift method
97. Early international results of laparoscopic gastrectomies
98. Laparoscopically assisted distal gastrectomy for early gastric cancer: Is it superior to open surgery?
99. Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy
100. Quality of life after laparoscopy-assisted Billroth I gastrectomy
101. Completely laparoscopic extragastric lymph node dissection for gastric malignancies located in the middle or lower third of the stomach
102. Laparoscopic total gastrectomy with distal pancreatosplenectomy and D2 lymphadenectomy for advanced gastric cancer
103. Incidence of lymph node metastasis from early gastric cancer: Estimation with a large number of cases at two centers
104. Indication for and outcome of laparoscopy-assisted Billroth I gastrectomy
105. Devine exclusion for unresectable carcinoma of the stomach
106. Gastric exclusion for unresectable gastric cancer
107. Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma